Stay updated with breaking news from Dimitri Borchtch. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Consolidated sales of €75.4m, +15.8% at constant exchange rates, after application of IFRS 5 Updating of the Group's 2022-2023 guidance excluding Novastep (foot and ankle activities): sales
Regulatory News: Amplitude Surgical (ISIN: FR0012789667, Ticker: AMPLI, eligible for PEA-PME savings plans), a leading French player on the surgical technology market for lower-limb orthopedics, announces
Consolidated sales after application of IFRS 5: €45.2m, +10.8% at constant exchange rates Sales before application of IFRS 5 (including foot and ankle activities): €56.4m, +14.2% at constant
Consolidated sales after application of IFRS 5: €19.4m, +11.3% at constant exchange rates Sales before application of IFRS 5 (including foot and ankle activities): €23.9 million, +14.1% at
Consolidated annual sales of €87.6 million, +4.8% at constant exchange rates, after the restatement of foot and ankle activities as activities held for sale Increase in EBITDA to €22.0 million